Accolate

Active Ingredient(s): Zafirlukast
FDA Approved: * September 26, 1996
Pharm Company: * ASTRAZENECA
Category: Asthma

Zafirlukast is an orally administered leukotriene receptor antagonist (LTRA) used for the chronic treatment of asthma. While zafirlukast is generally well tolerated, headache and stomach upset often occur. Some rare side effects can occur, which can be life-threatening, such as liver failure. Churg-Strauss syndrome has been associated with zafirlukast, but the relationship isn't thought to be causative in nature. Overdoses of zafirlukast tend to be self-limiting. Zafirlukast, like other LTRAs... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Accolate ACCOLATE10
Accolate 10 mg Oral Tablet
NDC: 0310-0401
Labeler:
Astrazeneca Pharmaceuticals Lp
Accolate ACCOLATE20
Accolate 20 mg Oral Tablet
NDC: 0310-0402
Labeler:
Astrazeneca Pharmaceuticals Lp
Accolate ACCOLATE20
Accolate 20 mg Oral Tablet
NDC: 53808-0203
Labeler:
State of Florida Doh Central Pharmacy
Accolate 10 mg Oral Tablet, Film Coated
NDC: 49884-010
Labeler:
Par Pharmaceutical Inc.
Accolate 20 mg Oral Tablet, Film Coated
NDC: 49884-011
Labeler:
Par Pharmaceutical Inc.
Accolate 10 mg Oral Tablet, Coated
NDC: 49884-589
Labeler:
Par Pharmaceutical Inc.
Accolate 20 mg Oral Tablet, Coated
NDC: 49884-590
Labeler:
Par Pharmaceutical Inc.

Popular Topics

Accolate availability

Are there any lower cost substitutes for Accolate? Anyone know when the patent on it runs out? ## I have received no rep...

1 REPLY